Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

Qing Zhou(National Human Genome Research Institute), Dan Yang(National Heart Lung and Blood Institute), Amanda K. Ombrello(National Human Genome Research Institute), Andrey V. Zavialov(University of Turku), Camilo Toro(National Human Genome Research Institute), Anton V. Zavialov(University of Turku), Deborah L. Stone(National Human Genome Research Institute), Jae Jin Chae(National Human Genome Research Institute), Sergio D. Rosenzweig(National Institute of Allergy and Infectious Diseases), Kevin Bishop(National Human Genome Research Institute), Karyl S. Barron(National Institute of Allergy and Infectious Diseases), Hye Sun Kuehn(National Institutes of Health Clinical Center), Patrycja Hoffmann(National Human Genome Research Institute), Alejandra Negro(National Heart Lung and Blood Institute), Wanxia Li Tsai(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Edward W. Cowen, Wuhong Pei(National Human Genome Research Institute), Joshua D. Milner(National Institute of Allergy and Infectious Diseases), Christopher Silvin(National Human Genome Research Institute), Theo Heller(National Institute of Diabetes and Digestive and Kidney Diseases), David T. Chin(National Human Genome Research Institute), Nicholas J. Patronas(National Institutes of Health Clinical Center), John S. Barber(National Institute of Allergy and Infectious Diseases), Chyi‐Chia Richard Lee, Geryl Wood(National Human Genome Research Institute), Alexander Ling(National Institutes of Health Clinical Center), Susan J. Kelly(Duke Medical Center), David E. Kleiner, James C. Mullikin(National Human Genome Research Institute), Nancy J. Ganson(Duke Medical Center), Heidi H. Kong, Sophie Hambleton(Newcastle University), Fabio Candotti(National Human Genome Research Institute), Martha Quezado, Katherine R. Calvo(National Institutes of Health Clinical Center), Hawwa Alao(National Institute of Diabetes and Digestive and Kidney Diseases), Beverly Barham(National Human Genome Research Institute), Anne Jones(National Human Genome Research Institute), James F. Meschia(Jacksonville College), Bradford B. Worrall(University of Virginia), Scott E. Kasner(Philadelphia University), Stephen S. Rich(University of Virginia), Raphaela Goldbach‐Mansky(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Mario Abinun(Newcastle University), Elizabeth Chalom(Saint Barnabas Medical Center), Alisa Gotte(Scottish Rite Hospital), Marilynn Punaro(Scottish Rite Hospital), Virginia Pascual(Baylor University), James Verbsky(Medical College of Wisconsin), Troy R. Torgerson(Seattle Children's Hospital), Nora G. Singer(MetroHealth Medical Center), Timothy R. Gershon, Seza Özen(Hacettepe University), Ömer Karadağ(Hacettepe University), Thomas A. Fleisher(National Institutes of Health Clinical Center), Elaine F. Remmers(National Human Genome Research Institute), Shawn M. Burgess(National Human Genome Research Institute), Susan Moir(National Institute of Allergy and Infectious Diseases), Massimo Gadina(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Raman Sood(National Human Genome Research Institute), Michael S. Hershfield(Duke Medical Center), Manfred Boehm(National Heart Lung and Blood Institute), Daniel L. Kastner(National Human Genome Research Institute), Ivona Aksentijevich(National Human Genome Research Institute)
New England Journal of Medicine
February 19, 2014
Cited by 885Open Access
Full Text

Abstract

BACKGROUND: We observed a syndrome of intermittent fevers, early-onset lacunar strokes and other neurovascular manifestations, livedoid rash, hepatosplenomegaly, and systemic vasculopathy in three unrelated patients. We suspected a genetic cause because the disorder presented in early childhood. METHODS: We performed whole-exome sequencing in the initial three patients and their unaffected parents and candidate-gene sequencing in three patients with a similar phenotype, as well as two young siblings with polyarteritis nodosa and one patient with small-vessel vasculitis. Enzyme assays, immunoblotting, immunohistochemical testing, flow cytometry, and cytokine profiling were performed on samples from the patients. To study protein function, we used morpholino-mediated knockdowns in zebrafish and short hairpin RNA knockdowns in U937 cells cultured with human dermal endothelial cells. RESULTS: All nine patients carried recessively inherited mutations in CECR1 (cat eye syndrome chromosome region, candidate 1), encoding adenosine deaminase 2 (ADA2), that were predicted to be deleterious; these mutations were rare or absent in healthy controls. Six patients were compound heterozygous for eight CECR1 mutations, whereas the three patients with polyarteritis nodosa or small-vessel vasculitis were homozygous for the p.Gly47Arg mutation. Patients had a marked reduction in the levels of ADA2 and ADA2-specific enzyme activity in the blood. Skin, liver, and brain biopsies revealed vasculopathic changes characterized by compromised endothelial integrity, endothelial cellular activation, and inflammation. Knockdown of a zebrafish ADA2 homologue caused intracranial hemorrhages and neutropenia - phenotypes that were prevented by coinjection with nonmutated (but not with mutated) human CECR1. Monocytes from patients induced damage in cocultured endothelial-cell layers. CONCLUSIONS: Loss-of-function mutations in CECR1 were associated with a spectrum of vascular and inflammatory phenotypes, ranging from early-onset recurrent stroke to systemic vasculopathy or vasculitis. (Funded by the National Institutes of Health Intramural Research Programs and others.).


Related Papers

No related papers found

Powered by citation graph analysis